Know Cancer

or
forgot password

Treatment of Depressive Symptoms in Cancer Patients: Comparison of Light Therapy and Cognitive Therapy


N/A
18 Years
75 Years
Open (Enrolling)
Both
Treatment of Depressive Symptoms in Cancer Patients

Thank you

Trial Information

Treatment of Depressive Symptoms in Cancer Patients: Comparison of Light Therapy and Cognitive Therapy


Inclusion Criteria:



- having received a diagnosis for a stage I-III cancer within the past 18 months;

- having a score of 7 or higher on the depression subscale of the Hospital Anxiety and
Depression Scale (HADS-D)84 or of 14 or higher on the Beck Depression Inventory-II
(BDI-II);

Exclusion Criteria:

- have received bright light therapy in the past month or having previously received
cognitive therapy for depression;

- having severe cognitive impairments (e.g., diagnosis of Parkinson's disease,
dementia, or Mini-Mental State Examination [MMSE] score < 27);

- meeting DSM-IV criteria for a major depressive episode of severe intensity, or
another severe psychiatric disorder (e.g., psychotic, bipolar, or substance use
disorder);

- presenting suicidal ideations with a risk of acting out, or having attempted suicide
in the past five years;

- having started a new psychotropic medication or having modified the dosage or
frequency of use during the past two weeks;

- currently taking a photosensitive medication (e.g., lithium, L-tryptophan);

- having evidence of an ocular pathology from an optometrist exam or a medical
condition contraindicating the use of bright light therapy (e.g., severe cataracts,
glaucoma, diabetes).

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Changes in depressive symptoms

Outcome Time Frame:

Pre-treatment (at recruitment; about 2 weeks before starting the experimental condition of 8 weeks), post-treatment (immediately after the experimental condition of 8 weeks), 3-month follow-up and 6-month follow-up

Safety Issue:

No

Principal Investigator

Josée Savard, Ph.D.

Investigator Role:

Study Director

Investigator Affiliation:

Laval University Cancer Research Center

Authority:

Canada: Ethics Review Committee

Study ID:

H10-12-123

NCT ID:

NCT01637103

Start Date:

September 2011

Completion Date:

July 2014

Related Keywords:

  • Treatment of Depressive Symptoms in Cancer Patients
  • Cancer
  • Depression
  • Anxiety
  • Fatigue
  • Sleep
  • Quality of life
  • Cognitive therapy
  • Bright light therapy
  • Depression

Name

Location